Efficacy and safety of anti-PD-1 combined with demethylation in the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a prospective, double-arm, single center study
Latest Information Update: 02 May 2023
At a glance
- Drugs Azacitidine (Primary) ; Camrelizumab (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 26 Apr 2023 Status changed from not yet recruiting to recruiting.
- 30 Jul 2020 New trial record